Search clinical trials for: гиперактивность

Total 2093 results

Sanofi

Completed

Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia (Zolkids)

Attention Deficit Hyperactivity Disorder

United States, Canada
Cleveland Clinic Florida
Astellas Pharma US, Inc.

Unknown

Urinary Cytokines in Patients With Overactive Bladder (OAB)

Overactive Bladder | Urinary Tract Infection

United States
Bundang CHA Hospital
Hallym University Medical Center

Completed

Genetic Polymorphism and OROS-Methylphenidate Treatment in Attention Deficit Hyperactivity Disorder(ADHD)

Attention Deficit Hyperactivity Disorder

Korea, Republic of
Medway NHS Foundation Trust

Unknown

Cystoscopy Plus Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding

Overactive Bladder Syndrome | Voiding Dysfunction

United Kingdom
University Hospital Freiburg
Novartis

Completed

Pharmacokinetics of Two Extended-Release Formulations of Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD) (MPH-Kinetics)

Attention Deficit Hyperactivity Disorder

Germany
Shalvata Mental Health Center

Unknown

Evaluation of the Effect of rTMS on Attention in Adults Diagnosed With Attention-Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Israel
Sheba Medical Center
Bar-Ilan University, Israel

Unknown

Characterization of Executive Functions and Patterns of Eye Movements in Children With Developmental Disabilities

Autistic Disorder | Attention Deficit Hyperactivity Disorder | Developmental Coordination Disorder

Israel
University Of Perugia
University of Roma La Sapienza

Unknown

Botulinum A Toxin in Patients With Parkinson's Disease (Botox-PD)

Parkinson's Disease | Multiple System Atrophy | Detrusor Overactivity
Pfizer

Completed

A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031

Urinary Bladder, Overactive | Prostatic Hyperplasia | Erectile Dysfunction

Singapore
Maastricht University Medical Center

Unknown

Non-Micturation Bladder Activity in Relation to Self-Consciousness During Filling Phase and Sensation Measurement During the Filling Phase

Lower Urinary Tract Symptoms | Overactive Bladder Syndrome

Netherlands
Clinical Study Centers, LLC
Shire

Completed

Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD)

Sleep | Attention Deficit Hyperactivity Disorder

United States
Pfizer

Completed

Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome

Overactive Bladder Syndrome

United States
Pfizer

Completed

Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome

Overactive Bladder Syndrome

Germany
APOGEPHA Arzneimittel GmbH

Completed

Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder

Overactive Bladder
Pharmaceutical Research Network

Completed

Lumigan Versus Cosopt

Open-Angle Glaucoma

United States
Eli Lilly and Company

Completed

Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD

Attention Deficit Hyperactivity Disorder | Oppositional Defiant Disorder

Australia, Belgium, Denmark, Finland, Germany, Netherlands, Spain, United Kingdom
Pfizer

Completed

Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension Phase

Overactive Bladder

United States
GlaxoSmithKline

Completed

A Two-Part Study to Determine: Best Medication Formulation and Food Effect

Overactive Bladder

United States
Federal University of Rio Grande do Sul
Hospital de Clinicas de Porto Alegre

Completed

Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)

Bipolar Disorder | Attention Deficit Hyperactivity Disorder

Brazil
Federal University of Rio Grande do Sul

Completed

Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD

Bipolar Disorder | Attention Deficit Hyperactivity Disorder

Brazil
Lexicor Medical Technology, LLC

Completed

NeuroLex EEG-Based ADHD Assessment Aid, Pivotal Study (NEBA)

Attention Deficit Disorder With Hyperactivity

United States
MedtronicNeuro

Completed

A Cost Analysis of Interstim Therapy

Urinary Retention and Symptoms of Overactive Bladder (Urge, Frequency)

United States
Pfizer

Completed

Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar

Attention Deficit Disorder With Hyperactivity

United States
University of Aarhus

Completed

Surface Nerve Stimulation Treatment for OAB in Children

Overactive Bladder | Urinary Incontinence

Denmark
University of Aarhus

Completed

Programmable Timer in the Bladder Rehabilitation Treatment of OAB

Overactive Bladder | Urinary Incontinence

Denmark
University of Utah
National Institute of Mental Health (NIMH)

Completed

Further Studies of Attention Deficit Disorder - Residual Type (RT)

Attention Deficit Hyperactivity Disorder

United States
University of L'Aquila

Completed

Safety And Efficacy Of Solifenacin In Men With Overactive Bladder (OAB) And Detrusor Underactivity

Overactive Bladder | Detrusor Underactivity

Italy
University of British Columbia

Completed

Effects of L-Theanine in Boys With ADHD

Attention Deficit Hyperactivity Disorder

Canada
Pfizer

Completed

A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome

Overactive Bladder Syndrome

Germany
Astellas Pharma Inc

Completed

A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients

Urinary Bladder, Overactive

China
Pfizer

Completed

Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome

Overactive Bladder
Università degli Studi dell'Insubria

Completed

Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity

Overactive Bladder

Italy
Pfizer

Completed

A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring

Urinary Bladder, Overactive

Korea, Republic of
UCB Pharma

Completed

The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom Setting

Attention Deficit Hyperactivity Disorder
National Cancer Institute (NCI)

Completed

Assessment of Attentional Functioning in Children With HIV-1 Infection

HIV Infections | Paralysis | Attention Deficit Disorder With Hyperactivity

United States
National Institute of Mental Health (NIMH)

Completed

Genetic Aspects of Neurologic and Psychiatric Disorders

Schizophrenia | Bipolar Disorder | Attention Deficit Disorder With Hyperactivity | Mental Retardation | Mental Disorder Diagnosed in Childhood

United States
National Institute of Neurological Disorders and...

Completed

Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic Stimulation

Attention Deficit Disorder With Hyperactivity

United States
Avera Pharmaceuticals

Terminated

Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity

Overactive Bladder Syndrome

Netherlands, United Kingdom
Medice Arzneimittel Pütter GmbH & Co KG

Completed

Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD (EMMA)

Attention Deficit Hyperactivity Disorder

Germany
APOGEPHA Arzneimittel GmbH

Completed

Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence

Overactive Bladder | Urinary Incontinence | Children
Novartis
Procter and Gamble

Completed

Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder

Urinary Incontinence

United States
Novartis

Completed

A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.

Overactive Bladder Syndrome

United States
Novartis

Completed

A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder

Overactive Bladder Syndrome

United States
Novartis
Procter and Gamble

Completed

Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

Overactive Bladder (OAB)

United States
Novartis

Completed

Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

ADHD, ADD

United States
Novartis

Completed

Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14

ADHD

Germany
Imperial College London

Unknown

Pharmacological vs Surgical Treatment for Mixed Incontinence

Urinary Incontinence, Stress | Urinary Incontinence, Urge | Mixed Urinary Incontinence

United Kingdom
Eli Lilly and Company

Completed

Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Japan
New River Pharmaceuticals

Completed

Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories

Substance-Related Disorders | Attention Deficit Disorder With Hyperactivity | Amphetamine-Related Disorders

United States
New River Pharmaceuticals

Completed

Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse

Substance-Related Disorders | Attention Deficit Disorder With Hyperactivity | Amphetamine-Related Disorders

United States

3

Subscribe